President and CEO of Sequenom Inc. (SQNM, Financial) Harry Stylli buys 2,000 shares of SQNM on 03/13/2009 at an average price of $13.43 a share.
Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health agriculture and livestock. These variations are the differences between individuals including disease predispositions and variations in drug responses. Single nucleotide polymorphisms are the most common variations. The company has developed the MassArray system an accurate cost-effective technology that is capable of high throughput single nucleotide polymorphism analysis at high speeds. Sequenom Inc. has a market cap of $850.1 million; its shares were traded at around $14.01 with and P/S ratio of 18.
Recent Trades of Sequenom Inc. by CEO:
Recent Trades of Sequenom Inc. by CFO:
Recent Trades of Sequenom Inc. by Directors and Officers:
Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health agriculture and livestock. These variations are the differences between individuals including disease predispositions and variations in drug responses. Single nucleotide polymorphisms are the most common variations. The company has developed the MassArray system an accurate cost-effective technology that is capable of high throughput single nucleotide polymorphism analysis at high speeds. Sequenom Inc. has a market cap of $850.1 million; its shares were traded at around $14.01 with and P/S ratio of 18.
Recent Trades of Sequenom Inc. by CEO:
- Buy: President and CEO Harry Stylli bought 2,000 shares of SQNM stock on 03/13/2009 at the average price of $13.43; the price of the stock has increased by 4.32% since.
- Buy: President and CEO, Director Harry Stylli bought 10,000 more shares of SQNM stock on 02/13/2009 at the average price of $16.5; the price of the stock has decreased by 15.09% since.
Recent Trades of Sequenom Inc. by CFO:
- Buy: CFO Paul W Hawran bought 2,000 shares of SQNM stock on 03/13/2009 at the average price of $13.46; the price of the stock has increased by 4.09% since.
- Buy: CFO Paul W Hawran bought 5,000 more shares of SQNM stock on 03/04/2009 at the average price of $13.45; the price of the stock has increased by 4.16% since.
Recent Trades of Sequenom Inc. by Directors and Officers:
- Buy: Director John A Fazio bought 500 shares of SQNM stock on 03/06/2009 at the average price of $12.75; the price of the stock has increased by 9.88% since.
- Buy: Director John A Fazio bought 500 more shares of SQNM stock on 02/13/2009 at the average price of $16.95; the price of the stock has decreased by 17.35% since.
- Sell: VP, Business Development Karsten Schmidt sold 5,000 shares of SQNM stock on 12/24/2008 at the average price of $19.88; the price of the stock has decreased by 29.53% since.
- Sell: Director Ernst-gunter Afting sold 6,300 shares of SQNM stock on 12/09/2008 at the average price of $16.52; the price of the stock has decreased by 15.19% since.
